Previous Page  14 / 17 Next Page
Information
Show Menu
Previous Page 14 / 17 Next Page
Page Background

Page 40

Notes:

conferenceseries

.com

Volume 5, Issue 3 (Suppl)

Occup Med Health Aff, an open access journal

ISSN:2329-6879

Occupational Health-2017

September 13-14, 2017

.

September 13-14, 2017 | Dallas, USA

Occupational Health & Safety

6

th

International Conference and Exhibition on

Prevalence of multi-drug resistant tuberculosis and implementation of infection prevention steps in a

tertiary care hospital in south Asia for M D R tuberculosis

Ruchi Girotra

SCMA®, Canada

M

ulti Drug Resistance (MDR) in tuberculosis (TB) is a global threat especially in Immunocompromised patients with India

and China carrying the greatest estimated burden of multidrug tuberculosis (MDR), multidrug-resistant (MDR) tuberculosis

is defined as disease caused by strains of

Mycobacterium tuberculosis

that are at least resistant to treatment with Isoniazid and

Rifampicin. WHO’s refreshed policy document continues to strongly advise that Xpert MTB/RIF be used as the initial diagnostic

test in both adults and children who are at risk of MDR-TB or HIV-associated TB, and that these two groups should be prioritized

for testing with Xpert MTB/RIF when resources are limited. We Used Xpert MTB/RIF system in our Hospital to predict prevalence

of MDR pulmonary TB in at risk population and thereby suggest Infection prevention measures to prevent the spread. The case

finding for clinical tuberculosis was based on clinical history criteria defined according to WHO’s guidelines for the programmatic

management of drug-resistant TB. A total of 100 sputum specimens of patients >18 years of age and suspected of MDR pulmonary

TB were followed over a period of 6 months. Average age of patients was 37 years and 52 specimens tested positive for pulmonary

TB and rifampicin resistance was detected in 49% of positive cases indicating high prevalence of rifampicin resistance and thereby

suggesting multi drug resistance. Rifampicin resistance is a reliable proxy for MDR-TB in patient groups in many countries. Based

on the findings, the infection prevention department suggested the following infection prevention steps in chest and tuberculosis

department of the hospital to prevent TB exposure to staff and patients, and to reduce the spread of infection by ensuring rapid

diagnosis and treatment. They are: Screening of TB suspects or patients on TB medications, education of patients, separation of

TB suspects from other patients, triaging, regular training programs, use of respirators (N-95) were promoted in bronchoscopy or

specialized treatment centers and implementation of environmental measures. This study suggests that XpertMTB/RIF can be used

as a rapid indicator of M D R tuberculosis in resource limited hospitals to enable smooth implementation of infection prevention

measures.

Biography

Ruchi Girotra has her expertise in infection prevention and infectious diseases. She is currently working as a General Manager for Specialty Certified Medical

Assistant (SCMA) and oversees the development of all study guides, exam content and other published materials for the medical assistance designation. She

has also played an active role in initiation and maintenance of Joint commission international standards, safe healthcare practices, sterilization and disinfection,

antibiotic stewardship programs in various hospitals. She has published several research papers in international and national medical journals.

ruchig@certitrek.com

Ruchi Girotra, Occup Med Health Aff 2017, 5:3 (Suppl)

DOI: 10.4172/2329-6879-C1-034